Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2

• Published in: Brain (London, England : 1878) England : 1878), 2002-05, Vol.125 (Pt 5), p.996-1004
• Main Authors: SPERFELD, A. D, HEIN, C, SCHRÖDER, J. M, LUDOLPH, A. C, HANEMANN, C. O
• Format: Article
• Language: English
• Subjects: Adult; Biological and medical sciences; Female; Humans; Male; Medical sciences; Middle Aged; Neurofibromatosis 2 - epidemiology; Neurofibromatosis 2 - pathology; Neurology; Peripheral Nerves - pathology; Peripheral Nerves - ultrastructure; Peripheral Nervous System Diseases - epidemiology; Peripheral Nervous System Diseases - pathology; Prevalence; Sural Nerve - pathology; Sural Nerve - ultrastructure; Tumors of the nervous system. Phacomatoses
• ISSN: 0006-8950; 1460-2156
• DOI: 10.1093/brain/awf115

Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder characterized by the occurrence of bilateral vestibular schwannomas, various brain and spinal tumours as well as peripheral nerve tumours, cutaneous tumours and juvenile posterior lenticular opacity. NF2 is caused by mutations in both alleles of a tumour suppressor gene coding for a protein called schwannomin or merlin. It is suggested that the development of NF2 tumours is caused by complete inactivation of the merlin/schwannomin gene. Interestingly, in a NF2 mouse model, peripheral nerve pathology was more frequently described than schwannomas. However, review of the literature shows that patients suffering from NF2 seldom have unexplained clinical features of peripheral nerve lesion unrelated to tumour masses. Single case reports describe sural nerve biopsies, which histologically show onion-bulb-like formations, seemingly originating from Schwann cells. We have conducted a systematic investigation to determine the occurrence and aetiology of peripheral nerve involvement in NF2 patients. We investigated 15 patients with definite NF2 and in 10 of these found electrophysiological evidence of neuropathy. In this study we present the classification of neuropathy, correlation to clinical findings, and histological findings of a sural nerve biopsy. We conclude that peripheral neuropathy, mostly of axonal type, is a common clinical finding in NF2. We hypothesize that the aetiology of this frequent peripheral neuropathy syndrome in NF2 is caused by compression effects of multiple tumourlets, originating along the length of the peripheral nerves on adjacent nerve fibres, by local influences of the endoneurial pathological cells on adjacent nerve fibres and/or the inability of these cells to properly adhere to, or ensheath, the axon.